Sana Historical Cash Flow
| SANA Stock | USD 2.61 0.26 11.06% |
Analysis of Sana Biotechnology cash flow over time is an excellent tool to project Sana Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cashflows From Investing Activities of 254.3 M or Other Cashflows From Financing Activities of 118.4 M as it is a great indicator of Sana Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Sana Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sana Biotechnology is a good buy for the upcoming year.
Sana |
About Sana Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Sana balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sana's non-liquid assets can be easily converted into cash.
Sana Biotechnology Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Capital Expenditures
Capital Expenditures are funds used by Sana Biotechnology to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Sana Biotechnology operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Sana Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Sana Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sana Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.At present, Sana Biotechnology's Investments are projected to increase significantly based on the last few years of reporting. The current year's Total Cashflows From Investing Activities is expected to grow to about 254.3 M, whereas Change In Cash is projected to grow to (47.4 M).
| 2022 | 2023 | 2024 (projected) | Sale Purchase Of Stock | 601K | 540.9K | 513.9K | Issuance Of Capital Stock | 601K | 31.6M | 30.1M |
Sana Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
Sana Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sana Biotechnology cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (58.5M) | (228.7M) | (211.4M) | 231.4M | 172.0M | 180.6M | |
| Change In Cash | 50.4M | 45.1M | 134.9M | (74.6M) | (49.9M) | (47.4M) | |
| Stock Based Compensation | 1.5M | 5.8M | 22.4M | 38.3M | 35.5M | 19.0M | |
| Free Cash Flow | (111.7M) | (161.9M) | (280.9M) | (310.9M) | (273.6M) | (287.3M) | |
| Change In Working Capital | 10.5M | 6.2M | 9.8M | 7.5M | 18.6M | 9.6M | |
| Begin Period Cash Flow | 31.4M | 81.8M | 126.9M | 261.8M | 187.3M | 126.2M | |
| Total Cashflows From Investing Activities | (87.9M) | (252.6M) | (245.8M) | 210.6M | 242.1M | 254.3M | |
| Other Cashflows From Financing Activities | 223.7M | 435.7M | (245.8M) | 210.6M | 172.0M | 118.4M | |
| Depreciation | 1.8M | 5.9M | 11.1M | 15.6M | 24.6M | 25.8M | |
| Other Non Cash Items | 39.0M | 129.4M | 61.6M | (82.1M) | (49.0M) | (46.6M) | |
| Capital Expenditures | 26.2M | 23.9M | 29.9M | 20.9M | 20.0M | 22.2M | |
| Total Cash From Operating Activities | (85.5M) | (138.0M) | (251.1M) | (290.1M) | (253.6M) | (266.3M) | |
| Change To Operating Activities | 10.9M | 4.2M | 10.1M | 6.5M | 7.5M | 6.7M | |
| Net Income | (130.8M) | (285.3M) | (355.9M) | (269.5M) | (283.3M) | (297.4M) | |
| Total Cash From Financing Activities | 223.7M | 435.7M | 631.8M | 4.9M | 31.6M | 30.1M | |
| End Period Cash Flow | 81.8M | 126.9M | 261.8M | 187.3M | 137.3M | 151.4M | |
| Change To Netincome | 32.9M | 135.2M | 51.1M | 25.7M | 29.5M | 53.9M | |
| Change To Liabilities | (421K) | 2.0M | 5.6M | 12.0M | 13.8M | 14.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sana Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.40) | Return On Assets (0.31) | Return On Equity (0.93) |
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.